• Dr. Emily Schonfeld is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at the Weill Cornell Medical Center. (nyp.org)
  • Prior to joining Weill Cornell Medical Center, Dr. Schonfeld spent three years as an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Colorado Hospital. (nyp.org)
  • The Division of Gastroenterology and Hepatology accepts five fellows per academic year. (cuanschutz.edu)
  • Further, CDI treatment guidelines published by the Infectious Diseases Society of America and the American College of Gastroenterology now endorse FMT as a recommended therapy for rCDI unresponsive after 2 or more recurrences treated with antibiotics. (pharmacytimes.com)
  • Dr. Lee is a member of the American Association for the Study of Liver Disease, American Society of Transplantation, American Gastroenterological Association, and American College of Gastroenterology. (bcm.edu)
  • National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. (thieme-connect.com)
  • Her active research includes investigation of methods to optimize outcomes after pediatric liver transplant. (hopkinsmedicine.org)
  • 'Prehab' for Improved Liver Transplantation Outcomes Dr William Balistreri on new data suggesting the value of addressing frailty and malnutrition in patients awaiting liver transplantation. (medscape.com)
  • Innovations Are Brightening Liver Transplantation Outcomes Dr William Balistreri recaps the breakthroughs that are increasing options for patients on the liver transplant waitlist. (medscape.com)
  • New Insights Into Liver Disease and Transplantation Findings on new therapeutic options, long-term outcomes, and diagnostic tools were on view at the recent Liver Meeting. (medscape.com)
  • New Drugs Seek to Further Improve Outcomes in Hepatitis C At the recent Liver Meeting, the spotlight was on next-generation interferon- and ribavirin-free regimens. (medscape.com)
  • His research interests are in health outcomes and clinical epidemiology as they pertain to chronic liver disease, particularly NAFLD and liver transplantation. (unc.edu)
  • For highly selected patients with early stage (≤3 cm), unresectable hilar cholangiocarcinoma or cholangiocarcinoma arising in the setting of primary sclerosing cholangitis, the sequential combination of high-dose neoadjuvant radiotherapy with chemosensitization, brachytherapy, maintenance chemotherapy, and orthotopic liver transplantation achieves excellent outcomes, with a 65% rate of recurrence-free survival after 5 years. (medscape.com)
  • Ten-year outcomes after liver transplantation were "excellent" for hepatocellular carcinoma patients whose disease was successfully downstaged to within Milan criteria, validating national downstaging policies . (medpagetoday.com)
  • A Case-Series Study of Induction in Liver Transplantation: Outcomes and Economic Analysis. (doximity.com)
  • She is passionate about improving outcomes for patients with end-stage liver disease. (mayoclinic.org)
  • Lee TH, Branch AD, Viveiros Kathleen, Chan WW, Chascsa DM, Kwo PY, Dhanasekaran "Predictors of Clinical Outcomes of COVID-19 in Patients with Chronic Liver Diseases (COLD)-US Multicenter Study. (bcm.edu)
  • Whether you're a specialist or just curious about gastroenterology, 2023 Gastroenterology Conferences will provide an essential platform to learn, network, and gain invaluable insights into this field. (waset.org)
  • She next completed a fellowship in gastroenterology, hepatology and nutrition at Rady Children's Hospital at the University of California, San Diego. (hopkinsmedicine.org)
  • I am a board certified general surgeon with fellowship training in liver, kidney and pancreas transplant. (doximity.com)
  • Dr. Howard Lee completed his internal medicine residency, gastroenterology fellowship, and transplant hepatology fellowship at Duke University Medical Center. (bcm.edu)
  • Dr. Shields completed his pediatric gastroenterology fellowship at the University of Rochester Medical Center in Rochester, MA. (umassmed.edu)
  • He trained in Gastroenterology and Hepatology at the West Midlands Deanery, Birmingham, UK and completed two fellowship stints, his first in Transplant Hepatology at the Liver Unit at Queen Elizabeth Hospital in Birmingham and his second in Hepatobiliary endoscopy (ERCP and EUS) at the University College of London (UCL) before obtained his Completion of Certificate in Specialist Training (CCST) in 2011. (nuh.com.sg)
  • She went on to do a gastroenterology fellowship at the New York University School of Medicine and then a transplant hepatology fellowship at New York-Presbyterian Hospital/Columbia University Medical Center. (nyp.org)
  • Welcome to the University of Colorado Gastroenterology and Hepatology Fellowship Program! (cuanschutz.edu)
  • The GI Division has a Gastroenterology Training Grant to financially support fellows interested in performing research during their fellowship. (cuanschutz.edu)
  • At HUS we treat gastrointestinal symptoms and disorders in children, such as inflammatory bowel disease, other congenital and later-onset bowel diseases, liver diseases, celiac disease, and functional disorders such as reflux or functional bowel disorders. (hus.fi)
  • Matthew Shields, MD, assistant professor at UMass Chan Medical School has clinical interests including inflammatory bowel disease, liver disease and polyposis syndroms. (umassmed.edu)
  • Hepatitis C virus (HCV) infection is the leading reason for liver transplantation and a common cause of hepatocellular carcinoma, the most rapidly increasing cause of cancer-related deaths in the United States ( 1,2 ). (cdc.gov)
  • Introduction Orthotopic Liver Transplantation (OLT) is the potential curative treatment option for patients with end-stage liver disease (ESLD) or hepatocellular carcinoma (HCC) within organ procurement and transplantation network (OPTN) criteria. (medrxiv.org)
  • Orthotopic liver transplantation (OLT) is the main treatment for patients with end-stage liver disease of different etiologies, hepatocellular carcinoma(HCC), and acute liver failure[1,2] Biliary strictures represent the most frequent biliary complication after liver transplantation, accounting for approximately 40% of all biliary complications [3-5]. (researchsquare.com)
  • Dr. Schonfeld is a transplant hepatologist who specializes in the care of patients with all types of liver disease, including viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune liver disease, metabolic liver disease, cirrhosis, and hepatocellular carcinoma. (nyp.org)
  • Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease. (cdc.gov)
  • Hepatitis C virus (HCV) is a single-stranded RNA virus that causes liver inflammation that can progress over time to advanced fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) ( 1 - 3 ). (cdc.gov)
  • 3 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. (thieme-connect.com)
  • Dr. Sara Kathryn Smith is a pediatric gastroenterologist at the Johns Hopkins Children's Center in Baltimore, Maryland, specializing in the diagnosis and treatment of liver disorders, such as primary sclerosing cholangitis, autoimmune hepatitis, Wilson's disease, metabolic diseases, biliary atresia, non-alcoholic steatohepatitis (NASH), and acute liver failure. (hopkinsmedicine.org)
  • Gastroenterology is a rapidly evolving field of medicine that focuses on digestive system disorders and diseases. (waset.org)
  • Whether it be learning about the newest drugs in development or exploring emerging techniques in the treatment of gastrointestinal diseases, 2024 Gastroenterology conferences are sure to provide the latest information to help practitioners stay ahead in their profession. (waset.org)
  • We examine and treat children's gastrointestinal symptoms and diseases of the liver and bowels at our outpatient clinic and in inpatient care if necessary. (hus.fi)
  • Diagnostics and treatment of children's liver diseases falls under the gastroenterology specialty. (hus.fi)
  • The hope is to one day transplant these cells as a treatment for complex diseases such as liver failure. (mayoclinic.org)
  • Ye is a Professor of Autoimmune liver diseases and Translational Hepatology at the Institute of Immunology and Immunotherapy, University of Birmingham and Consultant Hepatologist at the Queen Elizabeth Hospital where he specialises in the management of autoimmune liver diseases, immune mediated liver injury and liver transplantation. (birmingham.ac.uk)
  • His team spearhead the bench to bedside regulatory T cells immunotherapy in autoimmune liver diseases. (birmingham.ac.uk)
  • His group basic science research aims to dissect the pathogenesis mechanism of autoimmune liver diseases, immune mediated and drug induced/check point inhibitors liver injury with TransOMICS approach, deep immune profiling and develop personalised and stratified therapies. (birmingham.ac.uk)
  • His team develop and deliver translational GMP Regulatory T clinical trials in autoimmune liver diseases. (birmingham.ac.uk)
  • During his PhD he dissected the recruitment mechanism of regulatory T cells and developed isolation of GMP-grade regulatory T cells to apply as new therapy in autoimmune liver diseases and liver transplantation. (birmingham.ac.uk)
  • His research group focus on basic discovery science in autoimmune liver diseases, develop translational cellular therapy and practice precision medicine. (birmingham.ac.uk)
  • Ye and his team explore the underlying immune balance in the early and late stage of autoimmune liver diseases. (birmingham.ac.uk)
  • We offer a three-year, intensive experience in all aspects of gastrointestinal diseases, including management of acute GI bleeding, liver transplantation, and outpatient management of acute and chronic GI diseases. (cuanschutz.edu)
  • In particular, it provides rapid assessments of diseases of the bile ducts and gall bladder, the liver and the pancreas. (charite.de)
  • Inclusion criteria: Locally advanced or metastatic and or unresectable HCC with diagnosis confirmed by histology or cytology or clinically by American Association for the Study of Liver Diseases criteria in cirrhotic patients. (who.int)
  • Once patients pass the one-year mark with stable liver function, a normal life expectancy is certainly achievable. (montefiore.org)
  • Patients with a very high Model for End-Stage Liver Disease (MELD) score at transplant and patients with acute liver failure are at higher risk for complications and a longer recovery, and their overall survival rates are also lower. (montefiore.org)
  • For patients with hepatitis C, recurrence of the hepatitis causing damage to the new liver is the most common reason for the new liver to fail. (montefiore.org)
  • Patients with liver cancer can experience recurrence of the cancer after transplant, even if the initial cancer was small. (montefiore.org)
  • Fortunately, recurrence is uncommon after transplantation (there is about a 30 percent risk of recurrence) if patients have early-stage liver cancer (Stage I or II). (montefiore.org)
  • Liver transplantation has emerged as an increasingly successful treatment for patients with end-stage liver disease (ESLD). (medscape.com)
  • In addition, the liver is an extremely vascular organ and extensive bleeding can occur in patients with portal hypertension due to ESLD. (medscape.com)
  • Patients with acute or chronic liver failure do not synthesize normal amounts of clotting factors II (prothrombin), VII, IX, and X. Decreased production of these factors may lead to a coagulopathy, which is typically identified by a prolonged prothrombin time (PT). (medscape.com)
  • Dr. Gupta specializes in treating children and adolescents with all types of liver disease and cares for patients pre- and post-liver transplant. (choa.org)
  • Fecal microbiota transplantation (FMT) from healthy individuals to patients with CDI has been used increasingly over the past several decades to restore healthy flora in the gut, thus breaking the cycle of recurrent CDI. (pharmacytimes.com)
  • We reviewed more than 300 articles, summarized new findings, and confirmed that marginal grafts are a feasible option for expanding options for patients on liver transplant waiting lists in emergency situations in LDLT ( e.g ., liver failure or hepatic encephalopathy). (wjgnet.com)
  • Although some indispensable treatments are needed to address the deficiencies of these grafts, recipients can receive a favorable prognosis, similar to that of patients who receive standard liver grafts, under these treatments. (wjgnet.com)
  • Carey, E.J., Gautam, M., Ingall, T. and Douglas, D.D. (2008) The Effect of Liver Transplantation on Autonomic Dysfunction in Patients with End-Stage Liver Disease. (scirp.org)
  • Fleisher, L.A., Fleckenstein, J.F., Frank, S.M. and Thuluvath, P.J. (2000) Heart Rate Variability as a Predictor of Autonomic Dysfunction in Patients Awaiting Liver Transplantation. (scirp.org)
  • Only therapy naïve adult patients, without multivisceral transplants, and without living donor transplants will be included. (medrxiv.org)
  • Cases of alcohol-associated liver disease (ALD) are increasing at a steady rate in the United States with more patients presenting with alcohol-associated hepatitis and alcohol-associated cirrhosis. (thieme-connect.com)
  • Dr. Smith is a trained pediatric transplant hepatologist, with special focus in caring for young liver transplant patients before and after surgery. (hopkinsmedicine.org)
  • Such patients may be at risk for worsening liver function or sepsis if treated with peginterferon. (medscape.com)
  • Vanderbilt Health performs more liver transplants than any other program in Tennessee, giving new hope and longer life to patients suffering from end-stage liver disease. (vanderbilthealth.com)
  • Calls for a shift to redefine non-alcoholic fatty liver disease (NAFLD) as metabolic associated fatty liver disease could result in the exclusion of lean patients with NAFLD, a meta-analysis suggested. (medpagetoday.com)
  • During clinical rotations in medical school, Kianna Nguyen encountered many patients with liver failure and was struck by a grim reality: Their only hope was a transplant. (mayoclinic.org)
  • Research provides us with the understanding to develop tools to make big changes in clinical problems like those facing patients with liver failure," says Nguyen. (mayoclinic.org)
  • Stem cell-derived liver cells could provide a renewable source of liver cells to serve as a treatment for patients with liver failure. (mayoclinic.org)
  • This could open the door to treatment for many liver patients who previously did not have any options," says Nguyen. (mayoclinic.org)
  • Clinical data of 14 patients suffering from biliary strictures after liver transplantation from June 2014 to January 2018 were retrospectively analyzed. (researchsquare.com)
  • From June 2014 to January 2018, 14 patients of biliary strictures after liver transplantation were enrolled in the study. (researchsquare.com)
  • At Baylor St. Luke's Medical Center, Dr. Lee sees pre-and post-transplant end-stage liver disease patients, including managing their long-term care and providing counseling before and after the transplant surgery. (bcm.edu)
  • Liver transplant patients at URMC have a one-year patient survival rate of 96 percent, and a one-year graft survival rate of 92 percent, surpassing expected rates for this type of surgery based on the acuity of patients who receive transplants at URMC. (rochester.edu)
  • The only liver transplant and live-donor liver transplant program in upstate New York, URMC is one of the leading programs in North America for liver transplantation, and one of the first two centers in the nation to offer transplants for select patients with advanced colorectal liver metastasis. (rochester.edu)
  • Civacir, the company's plasma-derived, polyclonal antibody product candidate, when approved, would be the first therapy for the prevention of the recurrence of hepatitis C-related liver disease in hepatitis C virus (HCV) positive liver transplant recipients, or in patients who received an HCV-positive liver. (salesandmarketingnetwork.com)
  • Currently, there are no marketed therapies specifically indicated for prevention of re-infection post-liver transplant in HCV-positive patients. (salesandmarketingnetwork.com)
  • Thomas H. McLain, chairman, chief executive officer and president, Nabi Biopharmaceuticals, stated, "Civacir is uniquely positioned to fill a critical gap in the care of liver transplant patients by preventing re-infection with hepatitis C during a period after surgery when other therapies cannot be used. (salesandmarketingnetwork.com)
  • She evaluates patients who need liver transplants, provides medical management to patients before and after liver transplant, and helps care for patients with end stage liver disease. (nyp.org)
  • Currently, approximately 16,000 patients are on the liver waiting list, and slightly more than 6,300 liver transplants were performed in 2008 ( United Network for Organ Sharing [UNOS] data as of September 15, 2009). (medscape.com)
  • However, only a small percentage of these patients ultimately are candidates for transplantation because other criteria are also used to determine candidacy. (medscape.com)
  • In PSC patients, colectomy has been linked to improved prognosis, especially following liver transplantation. (lu.se)
  • Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients. (cdc.gov)
  • Tumor necrosis factor-a -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients. (cdc.gov)
  • Low Molecular Mass Polypeptide 7 Single Nucleotide Polymorphism is Associated with the Progression of Liver Fibrosis in Patients Infected with Hepatitis C Virus Genotype 4. (cdc.gov)
  • Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. (cdc.gov)
  • Such findings have generated uncertainty regarding whether and how to treat these patients, particularly when they may soon be candidates for liver transplant. (cdc.gov)
  • Patients on a liver transplantation list. (who.int)
  • 2022 was a proficuous year in both the nonalcoholic fatty liver disease (NAFLD) and obesity fields. (nature.com)
  • Dr. Smith has been the co-investigator in NIH, FDA, and pharmacy-initiated studies for children with liver disease and post-liver transplant, including Hepatitis C and NAFLD/NASH. (hopkinsmedicine.org)
  • In 2019, Ye received Sir Jules Thorn Programme Grant Award to develop and deliver Regulatory T cells therapy in autoimmune liver disease. (birmingham.ac.uk)
  • Lee TH, Matta B, King BD, Hodges MR, Tillmann HL, Patel K. "MicroRNA-122 associates with serum APOB but not liver fibrosis markers in CHC genotype 1 infection. (bcm.edu)
  • The primary endpoints are progression of liver fibrosis on biopsies as well as HCV levels in liver and serum. (salesandmarketingnetwork.com)
  • CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection. (cdc.gov)
  • Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C. (cdc.gov)
  • Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. (cdc.gov)
  • Because of many transfusion-related complications, especially those from large-volume transfusions, alternative therapies and approaches to transfusion are being investigated in transplantation and other surgical fields. (medscape.com)
  • Novel Therapies for Cholestasis Dr William Balistreri reviews the latest data on treatments for primary sclerosing cholangitis, primary biliary cholangitis, and cholestasis-related pruritus, presented during the Liver Meeting. (medscape.com)
  • The shortage of donor organs and therapeutic options was at once frustrating and inspirational, triggering her research interest in cellular therapies for liver failure. (mayoclinic.org)
  • Available therapies have a poor efficacy and safety profile and re-infection of the transplanted liver is almost universal. (salesandmarketingnetwork.com)
  • It has contributed to the development of liver transplantation, being the first in the world to carry out an adult to adult live donor liver transplant in 1993. (wikipedia.org)
  • There are few reviews concerning the feasibility of using marginal liver grafts in living donor liver transplantation (LDLT). (wjgnet.com)
  • He has leveraged his position at UNC to participate in multi-disciplinary research projects such as using a forecasting technique relatively novel to the clinical medical literature called discrete event simulation, and using this methodology to predict liver donor availability over time. (unc.edu)
  • These include living donor transplant and dual-organ transplant for complex liver-heart and liver-kidney dysfunction. (vanderbilthealth.com)
  • We offer a living donor transplant program to reduce wait times for a healthy liver. (vanderbilthealth.com)
  • By using part of a liver from a living donor, the patient has a better chance of a longer, healthier life. (vanderbilthealth.com)
  • The microcapsule protects the cells from physical damage during bioprocessing and may be used to deliver signals that direct stem cells toward a desired tissue such as pancreas or liver tissue. (mayoclinic.org)
  • Criteria for resectability include absence of all of the following: retropancreatic and paraceliac nodal metastases or distant liver metastases, invasion of the portal vein or main hepatic artery (although some centers can offer vascular reconstruction), extrahepatic adjacent organ invasion, and disseminated disease. (medscape.com)
  • Her research is focused on redirecting human embryonic stem cells to become liver cells with the potential for cell, tissue and organ repair. (mayoclinic.org)
  • Assessment of five-year experience with abdominal organ cluster transplantation. (cancercentrum.se)
  • Post-liver transplantation (LT) recurrent or de novo hep atic steatosis is a common complication in recipients, irrespective of tran splantation indication. (wjgnet.com)
  • Method: Cross sectional study of 18 infants, 11 controls and 7 infants (post-liver transplantation) with an average age of 10 ± 4.5 months, was evaluated in pre- and post-liver transplant. (scirp.org)
  • He worked as a Consultant Transplant Hepatologist at St. James University Hospital, Leeds, UK in 2012 before moving to the Liver Transplant Unit at the University of Kentucky, USA as an Assistant Professor in Medicine where he served for 2 years. (nuh.com.sg)
  • Jeffrey Shih, MD, assistant professor at UMass Chan Medical School, is a cardiologist whose clinical interests include cardiovascular disease, cardiomyopathy, heart failure and transplantation. (umassmed.edu)
  • Curtis Barry, MD, assistant professor of Medicine at UMass Chan Medical School is a gastroenterologist/hepatologist who specializes in liver disease and liver transplantation. (umassmed.edu)
  • Measuring the alcohol in alcohol-associated liver disease: choices and challenges for clinical research. (thieme-connect.com)
  • Sid Barritt is trained in gastroenterology, hepatology, liver transplantation and clinical epidemiology. (unc.edu)
  • Sid Barritt is a hepatologist and clinical epidemiologist with a research interest in non-alcoholic fatty liver disease. (unc.edu)
  • Clinical Transplantation. (doximity.com)
  • Liver Grafts Procured By Other Transplant Teams : Economic and Clinical Impact to a Single Transplant Center. (doximity.com)
  • The URMC Liver Transplant program found great success in their clinical activities last year. (rochester.edu)
  • Subsequently, he joined his great colleagues in the Liver Medicine clinical team at the Queen Elizabeth Liver Transplant Unit in Birmingham as a Consultant Hepatologist. (birmingham.ac.uk)
  • Our previous proof of concept clinical trial with GMP Treg ( AUTUMN trial ) demonstrated that Treg migrate to human liver. (birmingham.ac.uk)
  • Henrik S. Rasmussen, M.D., Ph.D., senior vice president, clinical, medical and regulatory affairs, Nabi Biopharmaceuticals, stated, "There is a significant medical need to prevent the recurrence of hepatitis C-related liver disease in HCV-positive liver transplant recipients. (salesandmarketingnetwork.com)
  • The work during his MRC funded clinician scientist led to the first in autoimmune liver disease early phase trial on GMP Regulatory T cells homing to the human liver. (birmingham.ac.uk)
  • Alcoholic liver disease epidemiology in the United States: a retrospective analysis of 3 US databases. (thieme-connect.com)
  • The journal Obesity: Racial and Ethnic Differences in Secular Trends for Childhood BMI, Weight, and Height The journal Gastroenterology: The Epidemiology of Obesity. (cdc.gov)
  • Our transplant team of experienced surgeons uses the most advanced techniques and the latest equipment for the highest possible success rates in transplantations. (montefiore.org)
  • Our liver surgeons and hepatologists combine their expertise to create a personalized care plan that is right for you. (vanderbilthealth.com)
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. (doximity.com)
  • 10 Bertha M, Shedden K, Mellinger J. Trends in the inpatient burden of alcohol-related liver disease among women hospitalized in the United States. (thieme-connect.com)
  • Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared with Liver Disease of Other Etiologies Worldwide. (nuh.com.sg)
  • Comorbidities such as obesity and NASH have been shown to augment the deleterious effects of AUD and ALD, resulting in more advanced liver disease. (thieme-connect.com)
  • Seeking Less-Invasive Care in Obesity-Related Liver Disease At DDW 2017, the focus was on finding better ways to detect disease and encourage weight loss. (medscape.com)
  • Complication Burden and the Economic Impact of Obesity in Liver Transplantation. (doximity.com)
  • Ombitasvir/paritaprevir/ritonavir+daclatasvir and ribavirin associated drug induced liver injury and syndrome of inappropriate secretion of antiduretic syndrome: A case report Kumar R, Hsiang JC, Tan J, Thurairajah PH. (nuh.com.sg)
  • He also leads the UK drug induced liver injury immunology work stream with his team and AIH Immunology work. (birmingham.ac.uk)
  • Key developments included the discovery of novel proteomics-based biomarkers and potential therapeutic targets that regulate the recognition of molecules derived from gut microbiota to modulate liver injury. (nature.com)
  • Suspect Supplements: Unregulated OTC Meds and Liver Injury Mislabeled herbal products are wreaking havoc on livers. (medscape.com)
  • Research at URMC will be led by Truptesh Kothari, MD, MS , associate professor of Medicine in Gastroenterology/Hepatology. (rochester.edu)